Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
B-57The Temporal Onset of Cognitive Fatigue in Multiple Sclerosis.
Clinical spectrum of CNS aquaporin-4 autoimmunity.
Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice.
Frequent but nonspecific venous narrowing in paediatric multiple sclerosis.
[Cannabinoid drugs for neurological diseases: what is behind?].
Treatment of facial myokymia in multiple sclerosis with botulinum toxin.
Tractography Analysis of 5 White Matter Bundles and Their Clinical and Cognitive Correlates in Early-Course Schizophrenia.
Multiple sclerosis disease-modifying therapy prescribing patterns in ontario.
Chronic cerebrospinal venous insufficiency: Case-control neurosonography results.
Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment.
Incidence of Mood or Anxiety Disorders in Children of Parents with Multiple Sclerosis.
The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial.
Association of multiple sclerosis susceptibility variants and early attack location in the CNS.
Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study.
Monosymptomatic clinically isolated syndrome with sudden sensorineural hearing loss: case report and critical review of the literature.
Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other autoimmune indications
The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.
Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis.
Management of children with multiple sclerosis.
Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations.
Client-centred therapy in multiple sclerosis: More intensive diagnostic evaluation and less intensive treatment.
Clinically isolated syndromes and the relationship to multiple sclerosis.
Fingolimod for the Treatment of Intracerebral Hemorrhage: A 2-Arm Proof-of-Concept Study.
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.
No quiet surrender: molecular guardians in multiple sclerosis brain.
Pages
« first
‹ previous
…
132
133
134
135
136
137
138
139
140
…
next ›
last »